CRISPR is moving out of the lab and into your home. Mammoth’s at-home kit takes advantage of this natural ability by directing CRISPR to search for very specific sequences linked to particular ...

Scientists have developed an inexpensive new test that can rapidly diagnose COVID-19 infections, a timely advance that comes as clinicians and public health officials are scrambling to cope with ...

Synthego wants to make gene-editing tools more accessible to scientists around the world. To that end, the Bay Area biotech has raised $110 million in series C funding to ramp up capacity for its ...

BUFFALO, N.Y. — A lab course at the University at Buffalo is giving undergraduate biology students hands-on experience with CRISPR, a revolutionary gene-editing technique. CRISPR allows scientists to ...

Some genetic diseases are more straightforward than others. In cases like cystic fibrosis or Marfan syndrome, a mutation makes a gene defective, and that causes symptoms in a patient that are ...

OAKLAND — In an ordinary house tucked away on a quiet street in Oakland, Josiah Zayner stands over a container filled with green tree frogs with a syringe in hand. He carefully injects a liquid into a ...

A retrospective three-year analysis using real-world data on uptake of broad-based NextGen sequencing panels in community oncology practices. This is an ASCO Meeting Abstract from the 2020 ASCO Annual ...

WATSONVILLE — High school students in the biomedical engineering class at Mount Madonna School in Watsonville recently conducted a gene editing experiment using CRISPR technology under the guidance of ...

We have been lauding the benefits of CRISPR for a couple of years, and how different it is from GMOs—and how the perception from consumers is being managed. And it appears that 2019 may well be CRISPR ...

CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...

People are experimenting on themselves with unlicensed gene therapies and publicizing the events widely, prompting the US Food and Drug Administration (FDA) to issue a statement on November 21 ...